Genetic characterization of an H5N1 avian influenza virus from a vaccinated duck flock in Vietnam by Ogawa, Haruko et al.
Genetic characterization of an H5N1 avian influenza virus
from a vaccinated duck flock in Vietnam
Vuong Nghia Bui • Haruko Ogawa • Dai Quang Trinh • Tham Hong Thi Nguyen •
Nga Thi Pham • Duc Anh Truong • Anh Ngoc Bui • Jonathan Runstadler •
Kunitoshi Imai • Khong Viet Nguyen
Received: 23 February 2014 / Accepted: 14 May 2014 / Published online: 1 June 2014
 Springer Science+Business Media New York 2014
Abstract This study reports the genetic characterization
of a highly pathogenic avian influenza virus subtype H5N1
isolated from a moribund domestic duck in central Vietnam
during 2012. In the moribund duck’s flock, within 6 days
after vaccination with a commercial H5N1 vaccine (Re-5)
to 59-day-old birds, 120 out of 2,000 ducks died. Genetic
analysis revealed a substantial number of mutations in the
HA gene of the isolate in comparison with the vaccine
strains, Re-1 and Re-5. Similar mutations were also found
in selected Vietnamese H5N1 strains isolated since 2009.
Mutations in the HA gene involved positions at antigenic
sites associated with antibody binding and also neutralizing
epitopes, with some of the mutations resulting in the
modification of N-linked glycosylation of the HA. Those
mutations may be related to the escape of virus from
antibody binding and the infection of poultry, interpreta-
tions which may be confirmed through a reverse genetics
approach. The virus also carried an amino acid substitution
in the M2, which conferred a reduced susceptibility to
amantadine, but no neuraminidase inhibitor resistance
markers were found in the viral NA gene. Additional
information including vaccination history in the farm and
the surrounding area is needed to fully understand the
background of this outbreak. Such understanding and
expanded monitoring of the H5N1 influenza viruses cir-
culating in Vietnam is an urgent need to provide updated
information to improve effective vaccine strain selection
and vaccination protocols, aiding disease control, and
biosecurity to prevent H5N1 infection in both poultry and
humans.
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Introduction
The first isolation of highly pathogenic avian influenza
virus (HPAIV) of an H5N1 subtype was reported in the
Chinese province of Guangdong province in 1996 [1].
Subsequently, the virus has been isolated from wild birds
and domestic poultry in many countries in Asia, Europe,
and Africa [2–4]. HPAIVs not only threaten animal health
but also raise pandemic concern due to the evidence of
zoonotic transmission to humans [5, 6]. Since its first
detection, the H5N1 virus has undergone significant
genetic diversification resulting in 10 viral clades origi-
nating from clade 0 to clade 9. Among them, clade 2
showed significant genetic variation into numerous sub-
clades [7]. In addition, genetic reassortment has resulted in
rapid viral evolution and created favorable circumstances
for the emergence of new genotypes that may possess
unique characteristics [8–11]. Thus, it is imperative to
continue characterizing newly isolated HPAIVs to monitor
for genetic changes that alter the viral phenotype.
In Vietnam, H5N1 virus was detected in poultry for the
first time in 2001 [12]. The H5N1 HPAIVs frequently
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isolated from outbreaks during 2001–2005 belonged to
clade 1 [13]. In 2007, H5N1 clade 1 re-emerged and was
followed by introduction of the new clade 2.3.4. From 2007
until 2010, while H5N1 clade 1 circulated in Southern
Vietnam, H5N1 clade 2.3.4 was predominant in Northern
Vietnam, although in 2008, H5N1 clade 7 was reported and
from 2009, H5N1 clade 2.3.2.1 was sporadically detected
[13, 14]. By 2012, viruses of clade 2.3.2.1 were dominantly
circulating in Vietnam. The outbreaks in poultry have
caused adverse health and economic effects in Vietnam
[15–17]. In addition, Vietnam is one among the countries
with a high rate of infection in humans with high mortality
(125 infection cases with 62 fatalities as of Dec 10, 2013)
[18].
In order to reduce the number of infections in poultry
and in turn reduce the risk of human exposure and human
cases caused by H5N1 virus as a step toward controlling
the disease, the Vietnamese government has implemented a
vaccination program for poultry throughout the country.
This program has used inactivated Chinese vaccines
(Harbin Weike Biotechnology Development Company,
China) including Re-1 since 2005 and Re-5 since 2011 that
respectively derive their HA and NA genes from A/goose/
Guangdong/1/1996 (Gs/GD/1/96) and from A/duck/Anhui/
1/2006 (Dk/Anhui/1/06). However, H5N1 outbreaks have
still been sporadically reported in Vietnam. The FAO-OIE-
WHO Technical Update (http://www.fao.org/docrep/014/
al874e/ al874e00.pdf) reported on the evolution of HPAI
H5N1 viruses causing outbreaks in Vietnam until Sep-
tember 2011, and stated that the vaccines were effective for
clade 2.3.2.1 viruses except for one antigenic variant found
in 2011. However, Creanga et al. [19], who conducted
active virologic surveillance in Vietnam between Septem-
ber 2010 and September 2012, found the emergence of
multiple clade 2.3.2.1 H5N1 virus subgroups, highlighting
the continuous evolution of the circulating viruses. The
findings raise concern that the current use of H5N1 poultry
vaccines in Vietnam might not protect poultry against the
recent antigenic variant H5N1 viruses in clade 2.3.2.1.
Here we describe the molecular characterization of an
HPAI H5N1 virus isolated in 2012 from a Re-5 vaccinated
duck, which is one of the inactivated AIV vaccines most
widely used in Vietnam in recent years.
Materials and methods
Virus isolation and identification
In July 2012, a farm in Quang Binh province in central
Vietnam performed vaccination with Re-5 on 2,000 ducks
at 59 days of age. Six days after the vaccination, 120 ducks
were found dead. For AIV diagnosis in the flock, three
ducks were sent to the national laboratory. Among those
ducks, two were dead, and one was moribund. Viruses of
subtype H5N1 were recovered from all three ducks. Partial
sequences of the HA gene indicated that the three strains
were almost identical. In this paper, the virus from the
moribund duck is described. Since the duck was showing
neurological signs, the brain was collected from the duck
and prepared as a 10 % homogenate that was used for virus
isolation and the detection of influenza A virus using RT-
PCR according to the WHO manual [20]. Virus isolation
was carried out in 10-day-old embryonated eggs via
allantoic cavity inoculation. The virus titer was estimated
by 50 % egg-infective dose (EID50) according to the
Spearman Ka¨rber method. Virus subtyping using primers
specific for the H5N1 subtype was conducted according to
the WHO manual [20].
RNA extraction, RT-PCR and sequencing
Viral RNA was extracted from the infectious allantoic
fluids using ISOGEN-LS (Nippon Gene, Tokyo, Japan)
according to the manufacturer’s instructions. The viral
RNA was transcribed into cDNA using the Uni12 primer
(50-agcraaagcagg-30) and SuperScript III Reverse Trans-
criptase (Invitrogen, Carlsbad, CA) at 42 C for 60 min
followed by 70 C for 10 min. Using the cDNAs as tem-
plates, PCR was conducted using primers specific for the
H5 and N1 gene of AIV and the protocol recommended by
WHO [20]. RT-PCR was also conducted to amplify the full
length of the eight genomic segments by the method
reported by Hoffmann et al. [21]. The PCR products
obtained were separated by 1 % agarose gel electrophore-
sis and purified using a QIAquick Gel Extraction Kit
(Qiagen, Hilden, Germany). The purified PCR products
were sequenced using a BigDye terminator ver. 3.1 cycle
sequencing kit (Applied Biosystems, Foster City, CA) and
analyzed with an ABI PRISM 3500 Genetic Analyzer
(Applied Biosystems). The primer sets described above and
walking primers designed by us (sequences available upon
request) were used to obtain the full-length nucleotide
sequence of the eight viral gene segments. The complete
genome sequence of the isolate generated in this study was
deposited in GenBank under the accession numbers
KF182738 to KF182745.
Genetic analysis
The nucleotide sequences obtained were analyzed with the
Genetyx Ver. 10 software (GENETYX Corp., Tokyo,
Japan) and compared with other sequences available in
GenBank identified by BLAST homology searches (http://
www.ncbi.nlm.nih.gov/genomes/ FLU/FLU.html). Nucle-
otide sequences and deduced amino acid HA and NA
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sequences of the isolate were further compared with rep-
resentative Vietnamese strains and those of vaccine strains
including Gs/GD/1/96 (Re-1) and Dk/Anhui/1/06 (Re-5)
based on alignments by Clustal W, Ver. 1.4 using the
BioEdit Package, Ver. 7.2 software. Phylogenetic analysis
of the HA genes was conducted using a dataset containing
94 HA nucleotide sequences of Vietnamese H5N1 strains
isolated from 2004 to 2013, which are available in Gen-
Bank, the sequence obtained in this study, reference strains
and vaccine strains. The sequences were aligned by Clustal
W [22] and evolutionary distances were calculated using
Tamura-Nei model. The tree was constructed with Mega
6.06 software [23] using the maximum likelihood method
supported by 500 bootstrap replications.
Results and discussion
Infection with influenza virus was confirmed by RT-PCR
for detection of the Matrix gene of AIV in the brain
homogenate sample of the vaccinated moribund duck. The
virus was successfully recovered as a titer of 107.5 EID50/
ml in eggs inoculated with the sample and the isolate was
identified as AIV of the H5N1 subtype by RT-PCR. The
virus isolated from the duck brain sample was designed as
A/duck/Vietnam/QB1207/2012 (H5N1) (Dk/VN/QB1207/
12).
Phylogenetic analysis of the HA gene clearly indicated
that Dk/VN/QB1207/12 belonged to the Eurasian lineage
together with other Vietnamese strains during 2012–2013,
and those Vietnamese strains are closely related to
A/environment/Chang Sha/1/2009 and A/Hong Kong/
6841/2010, suggesting that they might share a common
ancestor. The Dk/VN/QB1207/12 isolate fell into clade
2.3.2.1 by phylogenetic analysis using the HA gene as we
recently reported [24]. On the other hand, Gs/GD/1/96 (Re-
1) and Dk/Anhui/1/06 (Re-5) were grouped in clade 0 and
clade 2.3.4, respectively. The HA gene sequence of Gs/GD/
1/96 was close to those of Vietnamese strains isolated in
2005, and that of Dk/Anhui/1/06 was close to those of
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bFig. 1 Phylogenetic tree of the full-length HA genes of HPAI H5N1
viruses. A/duck/Vietnam/QB1207/2012 (H5N1) (black square)
together with other H5N1 Vietnamese strains isolated from
2004–2013, the vaccine strain of Re-1 derived from A/goose/
Guangdong/1/96 (H5N1) (white circle), the vaccine strain of Re-5
derived from A/duck/Anhui/1/2006 (H5N1) (black circle) and other
representative strains of H5N1 are shown in the tree. The evolutionary
history was inferred using the maximum likelihood method. The
evolutionary distances were calculated using the Tamura-Nei model.
Numbers at each branch point indicate bootstrap values[60 % in the
bootstrap interior branch test. All positions containing gap and
missing data were eliminated. Phylogenetic analysis was conducted in
MEGA6. The scale bar indicates 0.01 nucleotide substitutions per site
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Vietnamese strains isolated in 2007 and 2009. Phylogenetic
analysis revealed that H5N1 viruses circulating in Vietnam
are undergoing genetic change, possibly by antigenic drift
and/or positive selection under immunological pressures
(Fig. 1).
The complete genome sequence and the deduced amino
acid sequences of Dk/VN/QB1207/12 were analyzed and
compared with other strains available in GenBank as well
as vaccine strains being used in Vietnam. Analysis of six
internal genes indicated that the genetic sequences of Dk/
VN/QB1207/12 were similar to those of other Vietnamese
strains isolated in 2012, which belong to H5N1 clade
2.3.2.1 with identity levels ranging from 96.13 to 100 %
(data not shown). The similarities of the HA and NA genes
were further compared with representative Vietnamese
strains of clade 2.3.2.1 isolated from 2009 to 2012 and
vaccine strains that have been used for poultry in Vietnam.
As shown in Table 1, the HA gene of Dk/VN/QB1207/12
shared high identity with those of Vietnamese strains iso-
lated in 2012 including OIE2202 (99.82 %) and LMB315
(99.70 %). However, nucleotide sequence similarity less
than 97.06, 97.18 and 95.84 % were observed between Dk/
VN/QB1207/12 and other Vietnamese strains in 2012,
2011, and 2009, respectively. On the other hand, the HA
gene of Dk/VN/QB1207/12 showed nucleotide identities of
91.79 and 93.83 % when it was compared with those of the
vaccine strains Gs/GD/1/96 and Dk/Anhui/1/06, respec-
tively. Comparison of amino acid sequence indicated that
Dk/VN/QB1207/12 shared homology with selected Viet-
namese strains ranging from 95.59 to 99.82 %. In contrast,
amino acid identity of the HA between Dk/VN/QB1207/12
and Dk/Anhui/1/06 (Re-5) was 93.82 % and between Dk/
VN/QB1207/12 and Gs/GD/1/96 (Re-1) was 91.19 %.
Those identities were the lowest levels or close to the
lowest level among comparisons between all Vietnamese
H5N1 strains and the vaccines strains (Table 1). A similar
result was obtained for the NA gene of Dk/VN/QB1207/12,
which shares homology with Vietnamese strains ranging
from 98.81 to 99.92 % at the nucleotide level and from
97.20 to 100 % at amino acid level. The NA gene of Dk/
VN/QB1207/12 was almost closely related to the OIE2202
NA gene sequence. In contrast, Dk/VN/QB1207/12 NA
showed nucleotide identities of 88.37 and 94.81 % and
amino acid identities of 91.89 and 95.76 % when compared
to Gs/GD/1/96 and Dk/Anhui/1/06, respectively (Table 2).
Although all the Vietnamese strains compared in this study
were H5N1 clade 2.3.2.1, substantial differences in the
nucleotide and amino acid sequences of the HA and NA
genes exist between these strains and between the H5N1
strains and the vaccine strains, including Re-5. These data
highlight the ongoing generation of genetic diversity in
H5N1 HPAIV. Thus, monitoring and molecular charac-
terization of isolates would provide useful information for
updating vaccine strain selection, especially in countries
like Vietnam where endemic disease still occurs with cir-
culating viruses of multiple clades and sub-clades.
The HA cleavage site sequence at position 320–331 of
Dk/VN/QB1207/12 contained multiple basic amino acids
(SPQRERRRKR/G), indicating an efficient cleavage by
intracellular proteases [25]. The multiple basic cleavage
site motif of Dk/VN/QB1207/12 was similar to the Dk/
Anhui/1/06 (Re-5 vaccine) and to almost all of the repre-
sentative Vietnamese strains except for the LBM66 and
27265 strains. It was also slightly different from Gs/GD/1/
96 (Re-1 vaccine) with a deletion of K at position 329
(Table 3). In addition, mutations at the receptor-binding
pocket of HA were not found in Dk/VN/QB1207/12 and all
representative Vietnamese strains [26] and the HA gene of
Vietnamese and vaccine strains maintained the avian
receptor-binding specificity at positions Q-222 and G-224
(Table 3) [27]. However, the HA of Dk/VN/QB1207/12
contained amino acid substitutions of K/R140N and K189R
when compared with the vaccine strains (Table 3). Posi-
tions 140 and 189 are reportedly involved in the major
neutralizing epitopes of H5N1 viruses including both
human and avian strains [28]. Additional mutations at
positions 129, 263, and 277 sites that may also be impor-
tant for antibody binding [29–31], were also found in the
HA protein of Dk/VN/QB1207/12 (Table 3). More inter-
estingly, mutation at HA position 140 of Dk/VN/QB1207/
12 and all the representative Vietnamese strains has
resulted in the generation of a N-linked glycosylation site
140NSS143, which is not carried by the vaccine strains Gs/
GD/1/96 and Dk/Anhui/1/06. On the other hand, the
154NNT156 glycosylation site found in the HA of Dk/
Anhui/1/06 was not retained in Dk/VN/QB1207/12 and
other representative Vietnamese strains nor in Gs/GD/1/96
(Table 3). The formation of a new site for potential gly-
cosylation or loss of a glycosylation site possibly indicates
the ability of the virus to evade the host response without
negatively impacting survival and biological activity [32].
It was reported that N-linked glycosylation of the HA
protein can mask the antigenic epitope on the HA, which
can result in altered virus receptor binding and also inhi-
bition of neutralizing antibody binding [33, 34]. Taken
together, the mutations at the antigenic site and the dif-
ferences in the glycosylation sites on the HA between Dk/
VN/QB1207/12 and the vaccine strains, especially Dk/
Anhui/1/06, may suggest that the current vaccine used in
Vietnam cannot protect poultry from infection with genetic
variants of clade 2.3.2.1 H5N1 viruses such as Dk/VN/
QB1207/12. The typical peak season for H5N1 outbreak
had been during January to February in Vietnam; however,
multiple H5N1 outbreaks began in June of 2012, which
was possibly related to a decline in protection by H5N1
poultry vaccines against H5N1 viruses, especially variants
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of clade 2.3.2.1 viruses, as well as an overall decline in
poultry vaccination coverage in Vietnam [19]. Dk/VN/
QB1207/12 was isolated from an outbreak which occurred
in July 2012, corresponding to the above-mentioned time
frame. Thus, it should be important to assess the efficacy of
the vaccines currently used against virus such as Dk/VN/
QB1207/12 and to clarify the phenotypic importance of the
changes found in the HA of Dk/VN/QB1207/12 using
reverse genetics and site-directed mutagenesis.
In addition to monitoring mutation of H5N1 viral
strains, optimizing the vaccination protocol is extremely
important for the countries that have been using an AI
vaccine for poultry. Current HPAI vaccine protocol in
Vietnam involves an administration of the inactivated Re-5
Table 1 Percent identity of the HA sequence of A/duck/Vietnam/QB1207/2012 in relation to representative Vietnamese H5N1 viruses of clade
2.3.2.1 and vaccine strains
Virus strains Representative Vietnamese strains in 2009–2012 Vaccine strains
2012 2011 2009
QB1207 OIE1287 OIE2202 LBM132 LBM315 LBM66 LBM57 27265 Anhui/06 GD/96
QB1207 96.94 99.82 97.06 99.70 94.49 97.18 95.84 93.83 91.44
OIE1287 98.41 96.72 99.54 96.72 94.61 98.44 96.30 94.36 92.03
OIE2202 99.82 98.23 96.84 99.48 94.20 96.84 95.78 93.66 91.27
LBM132 98.41 96.64 98.23 96.78 94.61 98.45 96.19 94.60 92.26
LBM315 99.64 98.05 99.47 98.05 94.15 96.78 95.60 93.66 91.27
LBM66 95.59 95.07 95.59 94.71 95.24 94.84 96.19 93.55 91.44
LBM57 98.23 99.11 98.05 99.11 97.88 94.54 96.60 94.71 92.26
27265 96.65 96.83 96.65 96.47 96.30 96.83 96.30 95.19 93.32
Anhui/06 93.82 94.35 93.82 94.35 93.82 93.48 93.82 95.07 95.43
GD/96 91.19 92.25 91.19 92.07 91.19 91.37 91.54 93.48 95.42
Percent identity of nucleotide (above the diagonal) and amino acid (below the diagonal) is shown
QB1207 A/duck/Vietnam/QB1207/2012, OIE1287 A/duck/Vietnam/OIE-1287/2012, OIE2202 A/duck/Vietnam/OIE-2202/2012, LBM132
A/duck/Vietnam/LBM132/2012, LBM315 A/muscovy duck/Vietnam/LBM315/2012, LBM66 A/muscovy duck/Vietnam/LBM66/2011, LBM57
A/muscovy duck/Vietnam/LBM57/2011, 27265 A/chicken/Vietnam/27265/2009, Anhui/06 A/duck/Anhui/1/2006, GD/96 A/goose/Guangdong/
1/1996
Table 2 Percent identity of the NA sequence of A/duck/Vietnam/QB1207/2012 in relation to representative Vietnamese H5N1 viruses of clade
2.3.2.1 and vaccine strains
Virus strains Representative Vietnamese strains in 2009–2012 Vaccine strains
2012 2011 2009
QB1207 OIE1287 OIE2202 LBM132 LBM315 LBM66 LBM57 27265 Anhui/06 GD/96
QB1207 97.55 99.92 97.55 99.55 98.29 97.48 96.81 94.81 88.37
OIE1287 98.21 97.63 99.85 97.42 97.42 98.45 97.28 95.11 88.47
OIE2202 100.00 98.21 97.63 99.63 98.37 97.56 96.89 94.88 88.45
LBM132 98.44 99.77 98.44 97.43 97.43 98.45 97.28 95.11 88.43
LBM315 99.77 97.99 97.77 98.21 98.01 97.35 96.66 94.81 88.65
LBM66 99.77 97.10 99.77 97.10 97.77 97.65 96.89 94.81 88.29
LBM57 97.55 98.66 97.55 98.66 97.32 96.65 97.51 95.18 88.17
27265 97.20 97.67 97.20 97.90 96.97 96.27 97.67 96.27 90.29
Anhui/06 95.76 96.21 95.76 96.43 95.76 95.10 95.99 97.44 91.42
GD/96 91.89 91.68 93.75 91.89 93.75 91.04 91.04 92.22 93.75
Percent identity of nucleotide (above the diagonal) and amino acid (below the diagonal) is shown
QB1207 A/duck/Vietnam/QB1207/2012, OIE1287 A/duck/Vietnam/OIE-1287/2012, OIE2202 A/duck/Vietnam/OIE-2202/2012, LBM132
A/duck/Vietnam/LBM132/2012, LBM315 A/muscovy duck/Vietnam/LBM315/2012, LBM66 A/muscovy duck/Vietnam/LBM66/2011, LBM57
A/muscovy duck/Vietnam/LBM57/2011, 27265 A/chicken/Vietnam/27265/2009, Anhui/06 A/duck/Anhui/1/2006, GD/96 A/goose/Guangdong/
1/1996
282 Virus Genes (2014) 49:278–285
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vaccine twice a year, 6 months apart. In the duck from
which Dk/VN/QB1207/12 was isolated, onset of disease
was 6 days post vaccination at 59 days of age (average of
the flock). This would imply that either the virus had been
persistently circulating in the region or virus was newly
introduced to the flock, despite the mass vaccination
campaign occurring in Vietnam. In this case, it is possible
that the decline in maternal antibody protection in juvenile
ducks exposes them to infection with circulating virus. This
case may also suggest that the 6 month interval between
vaccinations could leave gaps in protection, allowing flock
infection, requiring an improvement of vaccination proto-
col in Vietnam. However, investigating this possibility will
require careful collection of data addressing the factors
responsible for the persistent outbreaks in the country.
Immunosurveillance studies also should be undertaken to
monitor viral circulation in the field. Unfortunately, we
could not obtain sera from the flock prior to or after the
outbreak. This fact prevents us from determining if vac-
cination was performed in a time frame that provides
protection against H5N1 infection. Additional studies
including immunosurveillance using sentinel chickens/
ducks would be useful to improve strategies for disease
control.
The analysis of predicted amino acid sequence for the
NA of Dk/VN/QB1207/12 and representative Vietnamese
strains did not identify any of the amino acid substitutions
known to relate to the oseltamivir resistance (Table 4) [35,
36]. In the M2 protein of Dk/VN/QB1207/12, the S31A
mutation known to be involved in amantadine resistance
was also not seen. However, the M2 of Dk/VN/QB1207/12
contained an amino acid substitution at position 27 (V27I),
which may suggest a reduced susceptibility to amantadine
(Table 4) [37, 38]. Recently, Govorkova et al. [36] sys-
tematically examined the prevalence of NA inhibitor and
amantadine resistance among the HPAIVs circulating
worldwide, and reported that most of the HPAIVs are
likely to be susceptible to NA inhibitors while some pro-
portion will also be susceptible to amantadine. The genetic
features of Dk/VN/QB1207/12 seem to match that pre-
diction. However, continued monitoring of the antiviral
susceptibility of HPAIVs seems important to maintaining
therapeutic approaches for control of the disease in
humans.
Genetic analysis of other internal genes of Dk/VN/
QB1207/12 did not reveal any mutation that increases
virulence of the virus except in the NS gene. The analysis
of predicted amino acid sequence for NS1 of Dk/VN/
QB1207/12 showed a five amino acid deletion at positions
80–84 which has been reported to enhance cytokine
expression by macrophages [39]. The predicted NS1 amino
acid sequence of Dk/VN/QB1207/12 displayed an addi-
tional two mutations at S42A and E92D which might also
increase virulence of this virus in chicken and mice as well
as promoting inhibition of host immune responses as pre-
viously described [39, 40]. Furthermore, the PDZ binding
sequence at the C-terminus of the NS1 protein was ESEV,
which may correlate with H5N1 virulence in mammals
[41]. Hence, the pathogenicity of Dk/VN/QB1207/12 in
mammalian animal models should be explored for its
possible public health significance.
This study provides a genetic characterization of the
HPAI H5N1 virus recently isolated from a duck in a vac-
cinated flock in Vietnam. Genetic analysis revealed that
Table 3 Comparison of amino acid sequence of the HA of A/duck/Vietnam/QB1207/2012 with that of representative Vietnamese H5N1 viruses
of clade 2.3.2.1 and vaccine strains
Virus strains Antigenic site Receptor binding Glycosylation sites Cleavage site
129 140 189 263 277 222 224 10 11 23 140 154 165 286 484 543 320–331
QB1207 L N R T R Q G ? ? ? ? - ? ? ? ? SPQRERRR * KR/G
OIE1287 L N K T R Q G ? ? ? ? - ? ? ? ? SPQRERRR * KR/G
OIE2202 L N R T R Q G ? ? ? ? - ? ? ? ? SPQRERRR * KR/G
LBM132 L N K T R Q G ? ? ? ? - ? ? ? ? SPQRERRR * KR/G
LBM315 L N R T K Q G ? ? ? ? - ? ? ? ? SPQRERRR * KR/G
LBM66 L N R T R Q G ? ? ? ? - ? ? ? ? SPQIERRRRKR/G
LBM57 L N R T R Q G ? ? ? ? - ? ? ? ? SPQRERRR * KR/G
27265 L N R T R Q G ? ? ? ? - ? ? ? ? SPQRERRRRKR/G
GD/96 S R K A K Q G ? ? ? - - ? ? ? ? TPQRERRRKKR/G
Anhui/06 S K K A K Q G ? ? ? - ? ? ? ? ? SPLRERRRK * R/G
QB1207 A/duck/Vietnam/QB1207/2012, OIE1287 A/duck/Vietnam/OIE-1287/2012, OIE2202 A/duck/Vietnam/OIE-2202/2012, LBM132
A/duck/Vietnam/LBM132/2012, LBM315 A/muscovy duck/Vietnam/LBM315/2012, LBM66 A/Muscovy duck/Vietnam/LBM66/2011, LBM57
A/muscovy duck/Vietnam/LBM57/2011, 27265 A/chicken/Vietnam/27265/2009, Anhui/06 A/duck/Anhui/1/2006, GD/96 A/goose/Guangdong/
1/1996
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mutation in the HPAI H5N1 isolate might have been driven
by selection pressure due to herd immunity caused by
natural infection or vaccination. In spite of control mea-
sures such as enforcement of biosecurity, culling of
infected birds, and a vaccination program, HPAI H5N1
virus circulation has been persistent in Vietnam. Therefore,
continuous monitoring of genetic changes in HPAI H5N1
viruses like the one presented here and evaluation of the
efficacy of vaccines are extremely important for Vietnam
and all the countries where H5N1 outbreaks have not been
yet controlled. There is also an urgent need to develop a
vaccine that matches the circulating strains and a stan-
dardized program to maximize the benefit of the vaccina-
tion campaign.
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